A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients

$Image of A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients$

Bookmark Share

PRODUCT LITERATURE

A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients

Martino EA - Personal Name;

The treatment landscape for relapsed/refractory multiple myeloma (RRMM) is rapidly evolving, particularly for patients exposed or refractory to lenalidomide. With the aim of evaluating the relative efficacy of lenalidomide-free regimens as second-line treatment options, an updated network meta-analysis, incorporating phase II/III randomized controlled trials, has been conducted

Availability

Location name is not set Location name is not set

Ledomid-003

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Ledomid
Lenalidomide
Multiple Myeloma
Specific Detail Info: -
Statement of Responsibility: https://doi.org/10.1016/j.esmoop.2025.105514

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment